Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

AIM/FARN stock hub

AIM/FARN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/FARNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

83.8M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/FARN

In the news

Latest news · AIM/FARN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROEn/a

P25 -54.2P50 2.1P75 13.7

ROIC-297.2

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/FARN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

144

Groups with data

Currency

EUR

Showing 144 of 144 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	UK
Employees	33
Employees Change	8%
Employees Change Percent	32
Enterprise value	GBX 94.6M
Exchange	London Stock Exchange AIM
Financial currency	EUR
First seen	2026-05-10
Industry	Biotechnology
Isin	FI4000153309
Last refreshed	2026-05-10
Market cap	GBX 83.8M
Price	GBX 42.55
Price currency	GBX
Sector	Healthcare
Sic	2834
Symbol	aim/FARN
Website	https://faron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-28.38%
EV Earnings	-3.98x
P/B ratio	-5.19x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	GBX -23.8M
Net Income Growth Years	0%
Profit Per Employee	GBX -720,554
ROA	-85.32
Roa5y	-123.4
ROCE	1,190.8
ROIC	-297.2

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-14.68%
Cagr1y	-79.45%
Cagr3y	-44.86%
Cagr5y	-30.73%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	GBX 15M
Cash	GBX 10.7M
Current Assets	GBX 13.7M
Current Liabilities	GBX 16.3M
Debt	GBX 21.5M
Equity	GBX -16.1M
Interest Coverage	-15.96
Liabilities	GBX 31.1M
Long Term Assets	GBX 1.3M
Long Term Liabilities	GBX 14.8M
Net Cash	GBX -10.8M
Net Cash By Market Cap	GBX -12.87
Tangible Book Value	GBX -17.1M
Tangible Book Value Per Share	GBX -0.15
WACC	9.07

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.84
Net Working Capital	GBX -4.3M
Quick ratio	0.68
Working Capital	GBX -2.7M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.21%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-79.56%
1Y total return	-79.43%
200-day SMA	144.7
3Y total return	-83.24%
50-day SMA	46.32
50-day SMA vs 200-day SMA	50under200
5Y total return	-84.05%
All Time High	890
All Time High Change	-95.22%
All Time High Date	2018-02-28
All Time Low	38
All Time Low Change	11.97%
All Time Low Date	2026-04-14
ATR	4.35
Beta	1.11
Beta1y	0.25
Beta2y	0.31
Ch YTD	-76.36
High	44
High52	270
High52 Date	2025-06-02
High52ch	-84.24%
Low	40.55
Low52	38
Low52 Date	2026-04-30
Low52ch	11.97%
Ma50ch	-8.14%
Price vs 200-day SMA	-70.6%
RSI	43.6
RSI Monthly	33.51
RSI Weekly	22.28
Sharpe ratio	-1.46x
Sortino ratio	-1.62
Total Return	-26.21%
Tr YTD	-75.71
Tr1m	-16.57%
Tr1w	2.53%
Tr3m	-73.9%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX -17.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	153,695,050%
Net Borrowing	13,813,691
Shares Insiders	9.39%
Shares Institutions	2.81%
Shares Out	199,514,938
Shares Qo Q	8.03%
Shares Yo Y	26.21%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	203,463.3x
Bv Per Share	-0.14
Ch10y	-83.48
Ch1m	-16.57
Ch1w	2.53
Ch1y	-79.98
Ch3m	-74.6
Ch3y	-86.45
Ch5y	-87.11
Ch6m	-78.18
Change	-1.05%
Change From Open	1.31
Close	43
Days Gap	-2.33
Depreciation Amortization	189,441.9
Dollar Volume	2,143,413.7
Earnings Date	2026-08-26
EBIT	GBX -17.7M
EBITDA	GBX -17.5M
EPS	GBX -0.21
F Score	2
Financing CF	18,009,266
Fiscal Year End	December
Founded	2,003
Income Tax	GBX 1,745
Investing CF	-17,447
Is Primary Listing	1
Last Earnings Date	2026-03-04
Last Report Date	2025-12-31
Ma150	126.7
Ma150ch	-66.42%
Ma20	42.76
Ma20ch	-0.49%
Net CF	2,454,857
Next Earnings Date	2026-08-26
Open	42
Position In Range	57.97
Ppne	163,491
Price Date	2026-05-08
Relative Volume	0.25x
Share Based Comp	1,589,463
Tr6m	-77.58%
Volume	50,374

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/FARN pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/FARN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/FARN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.8%

Share of float held by funds and institutions

Insider ownership

+9.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+26.2%

Negative means the company is buying back shares.

Technical

AIM/FARN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.6

Neutral momentum band

Price vs 200-day MA

-70.6%

50/200-day relationship not available

Beta (5Y)

1.11

Moves roughly with the market

Sharpe ratio

-1.46

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/FARN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/FARN stock rating?

aim/FARN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/FARN analysis?

The full report lives at /stocks/aim/FARN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/FARN?

The latest report frames aim/FARN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/FARN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.